BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35233828)

  • 1. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
    Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
    Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
    Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N
    Dai Z; Liu H; Liao J; Huang C; Ren X; Zhu W; Zhu S; Peng B; Li S; Lai J; Liang L; Xu L; Peng S; Lin S; Kuang M
    Mol Cell; 2021 Aug; 81(16):3339-3355.e8. PubMed ID: 34352206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
    Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
    J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL5-mediated 18S rRNA m
    Dai Z; Zhu W; Hou Y; Zhang X; Ren X; Lei K; Liao J; Liu H; Chen Z; Peng S; Li S; Lin S; Kuang M
    Mol Ther; 2023 Nov; 31(11):3225-3242. PubMed ID: 37735874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.
    Xu H; Lin X; Li Z; He X; Li Y; Qiu L; Lu L; Liu B; Zhan M; He K
    J Gastroenterol; 2023 Sep; 58(9):925-944. PubMed ID: 37391589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
    Huang CS; Zhu YQ; Xu QC; Chen S; Huang Y; Zhao G; Ni X; Liu B; Zhao W; Yin XY
    Clin Transl Med; 2022 Jun; 12(6):e848. PubMed ID: 35696608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway.
    Fang Y; Liu L; Liu S; Hu L; Cai W; Wan X; Liu D; He Y; Zhu Z
    Eur J Pharmacol; 2020 Apr; 872():172915. PubMed ID: 31926993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer.
    Wang S; Gao S; Zeng Y; Zhu L; Mo Y; Wong CC; Bao Y; Su P; Zhai J; Wang L; Soares F; Xu X; Chen H; Hezaveh K; Ci X; He A; McGaha T; O'Brien C; Rottapel R; Kang W; Wu J; Zheng G; Cai Z; Yu J; He HH
    Gastroenterology; 2022 Apr; 162(4):1183-1196. PubMed ID: 34968454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
    Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
    Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of
    Pi J; Wang W; Ji M; Wang X; Wei X; Jin J; Liu T; Qiang J; Qi Z; Li F; Liu Y; Ma Y; Si Y; Huo Y; Gao Y; Chen Y; Dong L; Su R; Chen J; Rao S; Yi P; Yu S; Wang F; Yu J
    Cancer Res; 2021 May; 81(10):2651-2665. PubMed ID: 32788173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1 induces the accumulation of Foxp3
    Zhang G; Zheng G; Zhang H; Qiu L
    Int Immunopharmacol; 2023 May; 118():110091. PubMed ID: 37018979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.
    Deng G; Hu C; Zhu L; Huang F; Huang W; Xu H; Nie W
    Int J Mol Med; 2014 Sep; 34(3):661-8. PubMed ID: 24968753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice.
    Zhang S; Song X; Cao D; Xu Z; Fan B; Che L; Hu J; Chen B; Dong M; Pilo MG; Cigliano A; Evert K; Ribback S; Dombrowski F; Pascale RM; Cossu A; Vidili G; Porcu A; Simile MM; Pes GM; Giannelli G; Gordan J; Wei L; Evert M; Cong W; Calvisi DF; Chen X
    J Hepatol; 2017 Dec; 67(6):1194-1203. PubMed ID: 28733220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YTHDF1-enhanced iron metabolism depends on TFRC m
    Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
    Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
    [No Abstract]   [Full Text] [Related]  

  • 16. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X
    Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway.
    Xiang D; Gu M; Liu J; Dong W; Yang Z; Wang K; Fu J; Wang H
    Cancer Lett; 2023 Apr; 560():216144. PubMed ID: 36958694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression.
    Wang T; Xu C; Zhang Z; Wu H; Li X; Zhang Y; Deng N; Dang N; Tang G; Yang X; Shi B; Li Z; Li L; Ye K
    Hepatology; 2022 Nov; 76(5):1302-1317. PubMed ID: 35340039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways.
    Moon H; Park H; Chae MJ; Choi HJ; Kim DY; Ro SW
    BMC Cancer; 2022 Apr; 22(1):423. PubMed ID: 35439973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.